VIDEO: Younger people with NAFLD, COVID-19 at double risk for mortality

In this exclusive video, Thomas Berg, MD, head of the section of hepatology at The University of Leipzig, discusses data presented at The Digital International Liver Congress on the role of non-alcoholic fatty liver disease in COVID-19 mortality risk.

The study found a correlation between obesity and chronic liver disease with mortality in the disease.

Although liver comorbidities were not on the radar at the beginning of the pandemic, they have become clear risk factors, particularly among younger patients with NAFLD, who have a nearly two-fold mortality risk, according to the study.